WASHINGTON — Government regulators have again warned Dollar Tree’s parent company about importing drugs and cosmetics that could be tainted due to improper product testing during manufacturing. The products were also mislabeled by the Chinese manufacturers. The FDA told Greenbrier about violations at the Chinese companies as early as 2017. The FDA’s Nov. 6 warning to Greenbrier International says that the company continued to receive products from companies on “import alert,” even after Greenbrier International agreed not to. A spokesman for the Chesapeake, Virginia-based Dollar Tree said the company is cooperating with the FDA.

Source: International New York Times November 15, 2019 20:15 UTC